Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1163312

MiRNA in prostate cancer: challenges toward translation


Abramović Irena, Ulamec Monika, Katušić Bojanac Ana, Bulić-Jakuš Floriana, Ježek Davor, Sinčić Nino
miRNA in prostate cancer: challenges toward translation // Epigenomics, 12 (2020), 6; 543-558 doi:10.2217/epi-2019-0275. (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 1163312 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
MiRNA in prostate cancer: challenges toward translation

Autori
Abramović Irena, Ulamec Monika, Katušić Bojanac Ana, Bulić-Jakuš Floriana, Ježek Davor, Sinčić Nino

Izvornik
Epigenomics (1750-1911) 12 (2020), 6; 543-558

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
cancer biomarker ; liquid biopsy ; miRNA ; preanalytical variables ; prostate cancer.

Sažetak
Prostate cancer (PCa) represents the most commonly diagnosed neoplasm among men. miRNAs, as biomarkers, could further improve reliability in distinguishing malignant versus nonmalignant, and aggressive versus nonaggressive PCa. However, conflicting data was reported for certain miRNAs, and there was a lack of consistency and reproducibility, which has been attributed to diverse (pre)analytical factors. In order to address current challenges in miRNA clinical research on PCa, a PubMed-based literature search was conducted with the last update in May 2019. After identifying critical variations in designs and protocols that undermined clear-cut evidence acquisition, and reliable translation into clinical practice, we propose guidelines for most critical steps that should be considered in future research of miRNA as biomarkers, especially in PCa.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
UIP-2017-05-8138 - Epigenetički biomarkeri raka prostate (epiPro) (Sinčić, Nino, HRZZ - 2017-05) ( POIROT)

Citiraj ovu publikaciju:

Abramović Irena, Ulamec Monika, Katušić Bojanac Ana, Bulić-Jakuš Floriana, Ježek Davor, Sinčić Nino
miRNA in prostate cancer: challenges toward translation // Epigenomics, 12 (2020), 6; 543-558 doi:10.2217/epi-2019-0275. (međunarodna recenzija, pregledni rad, znanstveni)
Abramović Irena, Ulamec Monika, Katušić Bojanac Ana, Bulić-Jakuš Floriana, Ježek Davor, Sinčić Nino (2020) miRNA in prostate cancer: challenges toward translation. Epigenomics, 12 (6), 543-558 doi:10.2217/epi-2019-0275..
@article{article, year = {2020}, pages = {543-558}, DOI = {10.2217/epi-2019-0275.}, keywords = {cancer biomarker, liquid biopsy, miRNA, preanalytical variables, prostate cancer.}, journal = {Epigenomics}, doi = {10.2217/epi-2019-0275.}, volume = {12}, number = {6}, issn = {1750-1911}, title = {miRNA in prostate cancer: challenges toward translation}, keyword = {cancer biomarker, liquid biopsy, miRNA, preanalytical variables, prostate cancer.} }
@article{article, year = {2020}, pages = {543-558}, DOI = {10.2217/epi-2019-0275.}, keywords = {cancer biomarker, liquid biopsy, miRNA, preanalytical variables, prostate cancer.}, journal = {Epigenomics}, doi = {10.2217/epi-2019-0275.}, volume = {12}, number = {6}, issn = {1750-1911}, title = {miRNA in prostate cancer: challenges toward translation}, keyword = {cancer biomarker, liquid biopsy, miRNA, preanalytical variables, prostate cancer.} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font